allegation
The FDA warns of the risk of permanent blindness with Ozempic, Wegovy and other weight-loss drugs.
A allegation by fda. Statements are as reported by the cited publishers — not verified by DecisionGateway.
La FDA advierte del riesgo de ceguera permanente con Ozempic, Wegovy y otros fármacos para adelgazar.
Discussion
Related claims
The FDA requires a warning about a risk of sudden blindness with popular weight-loss drugs.noticias_telemundo · statementThere is an official American warning about Ozempic and Zepbound concerning a rare risk to eyesight.تحذير أميركي رسمي · allegationPeople are suddenly losing their sight because of Ozempic and other popular weight-loss drugs.Yhdysvaltain FDA · allegationOzempic carries a rare risk to eyesight.تحذير أميركي رسمي · allegationWeight-loss drugs may increase the risk of irreversible vision loss.fda · allegationA new eye warning about taking Ozempic or Wegovy raises questions.gulfnewsuae · statement